Subscribe

  • How Can We Help You?

    Global Problem Solving from Covington: Deal with Complex Problems Anywhere in the World

Plyler_Julie_1000x714_ENV

Julie M. Plyler

Special Counsel

New York +1 212 841 1090

  • About
  • Representative Matters
  • Credentials
  • About

    Julie Plyler counsels clients primarily on capital markets and securities matters, with particular experience in the life sciences and financial services industries.

    Julie represents clients in a variety of transactions, including initial public offerings, other primary and secondary registered offerings, and private placements (including in connection with reverse mergers). She also represents companies in connection with M&A and financing transactions. Julie advises public company clients across industries in the preparation of SEC periodic reports and proxy statements, Section 16 reporting, securities compliance matters and corporate governance matters.

    Julie’s recent pro bono work includes representing charitable organizations in connection with corporate formation and governance matters.

    Areas of Expertise

  • Practices and Industries
  • Representative Matters

    Transactional

    • The underwriters in the $88.8 million initial public offering of Anteris Technologies Global Corp.
    • Air Products and Chemicals, Inc. in a €1.0 billion registered Eurobond offering.
    • NewAmsterdam Pharma in its upsized $479 million public offering of ordinary shares and pre-funded warrants.
    • Cameco Corporation in connection with its $747.6 million equity financing in connection with its acquisition of an interest in Westinghouse and its $500 million at-the-market equity facility.
    • The underwriters in a $300 million subordinated notes offering for Independent Bank Corp.
    • Banca Intesa Sanpaolo on U.S. law aspects of its tender offer for, and subsequent acquisition of, UBI Banca.
    • Insmed Incorporated in public offerings of $575 million of convertible senior notes and over $1.5 billion of common stock.
    • Humacyte, Inc. in its $800 million deSPAC merger with Alpha Healthcare Acquisition Corp.
    • Omeros Corporation in concurrent public offerings of $210 million of convertible senior notes and $100 million of common stock.
    • REGENXBIO Inc. in a $230.3 million public offering of common stock.
    • TriState Capital Holdings in various capital markets offerings, including $121 million of depositary share offerings, $97.5 million of subordinated debt offerings and a $105 million private placement.
    • The underwriters in the initial public offerings of Trevi Therapeutics, Inc., Nightstar Therapeutics plc and UroGen Pharma Ltd.
    • Placement agents and institutional investors in PIPEs, including in connection with reverse mergers.
    • Johnson & Johnson in its sale of RoC Skincare.
    • Veritex Holdings, Inc. in its acquisition of North Avenue Capital, LLC.

    Advisory

    • Advises public companies on Exchange Act periodic reporting, proxy statements and Section 16 reporting.
    • Provides advice on compliance with stock exchange listing standards, board and committee independence and composition matters, committee charters, governance guidelines, and similar matters.

    Pro Bono

    • Represents Art on the Ave, a community-based organization dedicated to the elevation of local artists and the revitalization of neighborhoods, in its organization as a New York not-for-profit entity.
    • Represented the Jackie Robinson Foundation in connection with the construction and design of the Jackie Robinson Museum in lower Manhattan.

    Areas of Expertise

  • Credentials
    Education
    • University of Virginia School of Law, J.D., 2016
        • Virginia Law and Business Review, Senior Review Editor
    • University of Florida, M.P.H., 2012
    • Duke University, B.A., 2009
    Bar Admissions
    • New York

    Areas of Expertise

News and Insights

Events